LRMR
#3356
Larimar Therapeutics, Inc. - Common Stock
2.5 3 USD
-0.05%
Market Price
Secteur: Soins de Santé
Base: USD
Devise de Profit: USD
Range quotidien
Range Annuel
Changement quotidien
-5.24%
Changement Mensuel
-34.11%
Evolution sur 6 mois
-48.47%
Changement Annuel
-39.33%
Clôture Précédente
2.6 7
Open
2.6 6
Low
2.5 3
High
2.6 9
Financials
2024
Current report, Q2 FY2024
Larimar Therapeutics, Inc. current report, Q2 FY2024
8-K
Current report, 30 May 2024
Larimar Therapeutics, Inc. current report, 30 May 2024
8-K
Current report, 29 May 2024
Larimar Therapeutics, Inc. current report, 29 May 2024
8-K
Current report, 20 May 2024
Larimar Therapeutics, Inc. current report, 20 May 2024
8-K
Current report, 09 May 2024
Larimar Therapeutics, Inc. current report, 09 May 2024
8-K
Quarterly report, Q1 FY2024
Larimar Therapeutics, Inc. quarterly report, Q1 FY2024
10-Q
Current report, 14 Mar 2024
Larimar Therapeutics, Inc. current report, 14 March 2024
8-K
Current report, 14 Feb 2024
Larimar Therapeutics, Inc. current report, 14 February 2024
8-K
Current report, 13 Feb 2024
Larimar Therapeutics, Inc. current report, 13 February 2024
8-K
Current report, 12 Feb 2024
Larimar Therapeutics, Inc. current report, 12 February 2024
8-K